Sort
40,608 grants matching “prostate cancer”
Prostate, Lung, Colorectal and Ovarian (PLCO) Screening Trial
$1,935,456Barbara B O'Brien · Westat, Inc. · N01 · FY2013 · CA
REALIZING THE TRANSLATIONAL POTENTIAL OF TELOMERE LENGTH VARIATION AS A TISSUE-BASED PROGNOSTIC MARKER FOR PROSTATE CANCER
$1,932,472The Johns Hopkins University · · FY2012 · Department of Defense
Cancer Risk in Human Populations
$1,931,840Debra Silverman · Division Of Cancer Epidemiology And Genetics · ZIA · FY2020 · CA
Signal Processing And Instrumentation Section
$1,930,370Thomas J Pohida · Center For Information Technology · ZIA · FY2019 · CT
The Impact of DNA Damage Repair Abnormalities in Prostate Cancer
$1,929,187Philip W Kantoff · Sloan-Kettering Inst Can Research · P01 · FY2019 · CA
Contraceptive Discovery, Development and Behavioral Research Center
$1,928,523Gunda I. Georg · University Of Minnesota · P50 · FY2019 · HD
Contraceptive Discovery, Development and Behavioral Research Center
$1,928,523Gunda I. Georg · University Of Minnesota · P50 · FY2020 · HD
Contraceptive Discovery, Development and Behavioral Research Center
$1,928,523Gunda I. Georg · University Of Minnesota · U54 · FY2018 · HD
DEVELOPMENT OF TARGETED THERAPIES FOR METASTATIC PROSTATE CANCERS CLASSIFIED BY SUBTYPES OF DNA REPAIR DEFICIENCY
$1,927,373Fred Hutchinson Cancer Center · · FY2025 · Defense Health Agency
Center for Molecular Imaging Research at MGH/HMS
$1,923,146Ralph Weissleder · Massachusetts General Hospital · P50 · FY2010 · CA
Genetic Variation in Cancer Risk and Outcomes in African Americans
$1,919,811Ann G Schwartz · Wayne State University · P01 · FY2024 · CA
Systems Analysis of Epigenomic Architecture in Cancer Progression
$1,918,884Tim H.-M. Huang · University Of Texas Hlth Science Center · U54 · FY2017 · CA
University of Arizona Cancer Prevention Clinical Trials Network (UA CP-CTNet)
$1,918,750H-H. Sherry Chow · University Of Arizona · UG1 · FY2021 · CA
University of Arizona Cancer Prevention Clinical Trials Network (UA CP-CTNet)
$1,918,750H-H. Sherry Chow · University Of Arizona · UG1 · FY2020 · CA
Human Immune Responses to Tumor Antigens for Cancer Immunotherapy
$1,918,695Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
RACIAL DISPARITIES IN THE QUALITY OF PROSTATE CANCER CARE
$1,918,226Icahn School Of Medicine At Mount Sinai · · FY2011 · Department of the Army
Harvard Transdisciplinary Research in Energetics and Cancer Center
$1,917,696Frank B Hu · Harvard School Of Public Health · U54 · FY2015 · CA
Clinical and Immunologic Evaluation of ProstAtak for Prostate Cancer
$1,917,582Estuardo Aguilar-Cordova · Advantagene, Inc · R44 · FY2012 · CA
PLCO Trial Etiologic and Early Marker Study
$1,915,866Robert Hoover · Division Of Cancer Epidemiology And Genetics · ZIA · FY2013 · CA
RACIAL DIFFERENCES IN PROSTATE CANCER: INFLUENCE OF HEALTH CARE AND HOST AND TUMORE BIOLOGY
$1,914,828University Of North Carolina At Chapel Hill · · FY2008 · Department of the Army
Radiopharmaceutical Imaging and Therapy of Cancer
$1,914,491Peter L. Choyke · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Growth Factor Imaging and Photoimmunotherapy
$1,914,491Peter L. Choyke · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
NEUROENDOCRINE DIFFERENTIATION AND ENZALUTAMIDE RESISTANCE IN PROSTATE CANCER
$1,913,962Northwestern University · · FY2017 · Department of the Army
Effects of Public Information in Cancer (EPIC Center)
$1,913,763Robert C. Hornik · University Of Pennsylvania · P50 · FY2007 · CA
CCR Artificial Intelligence Resource
$1,912,857Baris Tãrkbey · Division Of Basic Sciences - Nci · ZIH · FY2025 · CA